16 research outputs found
Perinatal inflammation influences but does not arrest rapid immune development in preterm babies
Infection and infection-related complications are important causes of death and morbidity following preterm birth. Despite this risk, there is limited understanding of the development of the immune system in those born prematurely, and of how this development is influenced by perinatal factors. Here we prospectively and longitudinally follow a cohort of babies born before 32 weeks of gestation. We demonstrate that preterm babies, including those born extremely prematurely (<28 weeks), are capable of rapidly acquiring some adult levels of immune functionality, in which immune maturation occurs independently of the developing heterogeneous microbiome. By contrast, we observe a reduced percentage of CXCL8-producing T cells, but comparable levels of TNF-producing T cells, from babies exposed to in utero or postnatal infection, which precedes an unstable post-natal clinical course. These data show that rapid immune development is possible in preterm babies, but distinct identifiable differences in functionality may predict subsequent infection mediated outcomes
Immunohistochemical Expression of Angiogenesis and cell-adhesion Markers in Surgical and Autopsy NSCLC Tissue samples: Correlation with Clinicopathologic parameters and survival.
Immunohistochemical Expression of Angiogenesis and cell-adhesion Markers in Surgical and Autopsy NSCLC Tissue samples: Correlation with Clinicopathologic parameters and survival.
Immunohistochemical evaluation of cathepsin D in normal, hyperplastic and malignant endometrium: Correlation with hormone receptor status c-erbB-2, p53, Rb proteins and proliferation associated indices
The immunohistochemical expression of cathepsin D was performed in
paraffin embedded tissue from 79 endometrial carcinomas, 35 cases of
hyperplasia, and 32 normal endometrium using the streptavidin-biotin
method to investigate the role of cathepsin D (CD) in these lesions and
its possible relationship with other potential and established
prognostic markers. The association between CD and the other markers was
assessed by univariate analysis. Tumor cell CD expression was lower in
the group of carcinomas compared to the normal proliferative (P = 0.022)
and secretory endometrium (P = 0.0005). In addition, hyperplastic cell
CD expression was lower compared with epithelial cell CD expression in
the secretory phase of normal endometrium (P = 0.009). Malignant cell CD
expression was inversely correlated with tumor stromal cells (P =
0.007). A positive relationship of stromal cell CD expression with pRb
(P = 0.046) and PCNA score (P < 0.0001) was detected in the group of
carcinomas. In the proliferative phase of normal endometrium, epithelial
CD expression was positively correlated with estrogen status (P =
0.015). The data show that down-regulation of CD expression is an early
event in endometrial carcinogenesis. In addition, stromal cell CD
expression may be involved in cell growth process in endometrial
carcinomas